| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5K | -99.8% |
| R&D Expense | $16.3M | -34.9% |
| SG&A Expense | $12.2M | -7.0% |
| Operating Income | -$34.3M | +2.4% |
| Interest Expense | $1.9M | -39.1% |
| Net Income | -$35.1M | +6.9% |
| EPS (Basic) | -$2.20 | -1194.1% |
| EPS (Diluted) | -$2.20 | -1194.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.1M | -84.5% |
| Accounts Receivable | $1K | -75.0% |
| Current Assets | $8.3M | -84.6% |
| Total Assets | $8.3M | -87.3% |
| Current Liabilities | $2.0M | -91.9% |
| Long-term Debt | $0 | — |
| Total Liabilities | $2.0M | -92.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.1M | -3.1% |
| Capital Expenditures | $197K | -8.8% |
| Investing Cash Flow | $1.3M | +797.4% |
| Financing Cash Flow | -$18.1M | -384.9% |
| Free Cash Flow | -$30.3M | -3.0% |
| Stockholders' Equity |
| $6.3M |
| -83.6% |